tiprankstipranks
Trending News
More News >

Rajiv Patel Insider Profile

4 Followers
Rajiv Patel, Director, Member of Group Owning 10%, Ten Percent Owner at Nexvet Biopharma, holds 3.48M shares in Lantheus (Ticker: LNTH), holds 2.51M shares in Nexvet Biopharma (Ticker: NVET). Most recently, Rajiv Patel Sold ― shares of Lantheus on Aug 21, 2025 for an estimated value of $191.21M.
tipranks
Rajiv Patel

Rajiv Patel
Nexvet Biopharma (NVET)
Director, Member of Group Owning 10%, Ten Percent Owner

Ranked #75,858 out of 103,225 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-15.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$198M
100.00%
A breakdown of Rajiv Patel's holdings

Insider Roles

Lantheus
(LNTH)
Member of a Group Owning 10%
Roles that Rajiv Patel holds in companies

Most Profitable Insider Trade

Stock:
Nexvet Biopharma
(NVET)
Rating:Informative Buy
Date:Oct 02, 2015 - Oct 02, 2016
Return:+1.70%
The most profitable trade made by Rajiv Patel

Rajiv Patel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NVET
Nexvet Biopharma
Aug 02, 2017
Uninformative Sell
91.26K
$16.85M
Lantheus
Aug 21, 2025
Member of a Group Owning 10%
Informative Sell
191.21M
$197.65M
List of latest transactions for each holding click on a transaction to see Rajiv Patel's performance on stock

Rajiv Patel insider profile FAQ

What is the percentage of profitable transactions made by Rajiv Patel?
The percentage of profitable transactions made by Rajiv Patel is 40%.
    What is the average return per transaction made by Rajiv Patel?
    The average return per transaction made by Rajiv Patel is -15.00%.
      What stocks does Rajiv Patel hold?
      Rajiv Patel holds: NVET, LNTH stocks.
        What was Rajiv Patel’s latest transaction?
        Rajiv Patel latest transaction was an Informative Sell of $191.21M.
          What was Rajiv Patel's most profitable transaction?
          Rajiv Patel’s most profitable transaction was an Informative Buy of NVET stock on October 2, 2015. The return on the trade was 1.70%.
            What is Rajiv Patel's role in Nexvet Biopharma?
            Rajiv Patel's role in Nexvet Biopharma is Director, Member of Group Owning 10%, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.